In addition, EOBCs were composed more of HER2-enriched and triple-negative breast cancer (ie, estrogen receptors negative, progesterone receptors negative, and HER2 receptors negative) subtypes than LOBCs, while LOBCs showed a higher percentage of luminal subtype than EOBCs (P.018). The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.